Maximum quantity allowed is 999
Please select the quantity
CAS RN: 157716-52-4 | Product Number: P2831
Perifosine
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- 1,1-Dimethylpiperidin-1-ium-4-yl Octadecyl Phosphate
- 1,1-Dimethyl-4-piperidiniumyl Octadecyl Phosphate
Product Documents:
| Size | Unit Price | Shanghai | Tianjin | Japan* |
|---|---|---|---|---|
| 25MG |
¥460.00
|
1 | Contact Us | 9 |
* For order or inquiry, please contact
Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
| Product Number | P2831 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__5H__5__2NO__4P = 461.67 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (-20°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Moisture Sensitive,Heat Sensitive |
| CAS RN | 157716-52-4 |
| Reaxys Registry Number | 11186113 |
| PubChem Substance ID | 468592745 |
| MDL Number | MFCD00927554 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC)(CAD) | min. 98.0 area% |
| Melting point | 230.0 to 234.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 232 °C |
GHS
Related Laws:
| RTECS# | TN5910000 |
Transport Information:
| Customs Control Conditions (Q) |
Application
Perifosine: An Oral Akt Inhibitor
The PI3K/Akt/mTOR pathway is aberrantly active in most human cancer cells and contributes to cancer cell growth, proliferation, and survival. Perifosine, an alkyl phospholipid, is an oral Akt inhibitor that display potent anti-proliferative activity in human tumor models. Perifosine has been shown to target phosphatidylinositol 3-kinase (PI3K)/Akt signaling. (The product is for research purpose only.)
References
- Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation
- Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
- Perifosine: update on a novel Akt inhibitor (a review)
- Perifosine, an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity (a review)
- Current View on the Mechanism of Action of Perifosine in Cancer (a review)
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.